title: Hydralazine-induced pulmonary-renal syndrome:  a case report.
abstract: Drug-induced lupus erythematosus differs in its manifestation from drug-induced vasculitis. The former is associated with characteristic symptoms that improve following discontinuation, whereas the latter is predominantly an antineutrophil cytoplasmic antibody (ANCA) positive small vessel vasculitis involving the kidneys, skin, and lungs. We present a case of advanced disease in an elderly Caucasian woman requiring corticosteroids, and immunosuppressive therapy, who was on hydralazine for >2 years.
authors: Department of Medicine, Cooper University Hospital, Camden, NJ 08103, USA. ceo@kalrahospital.com
authors: Ankur
authors: A
authors: Kalra
authors: Naoto
authors: N
authors: Yokogawa
authors: Haroon
authors: H
authors: Raja
authors: Chandrasekar
authors: C
authors: Palaniswamy
authors: Priyank
authors: P
authors: Desai
authors: Sergio L
authors: SL
authors: Zanotti-Cavazzoni
authors: Sri-Sujanthy
authors: SS
authors: Rajaram
mesh_terms: D000368:Aged; D005260:Female; D005921:Glomerulonephritis / Q000139:chemically induced* / Q000503:physiopathology; D005938:Glucocorticoids / Q000627:therapeutic use; D006470:Hemorrhage / Q000139:chemically induced* / Q000503:physiopathology; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects* / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008171:Lung Diseases / Q000139:chemically induced* / Q000503:physiopathology; D014665:Vasodilator Agents / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D014665:Vasodilator Agents; D006830:Hydralazine